[go: up one dir, main page]

TN2013000135A1 - Solid state forms of a potent hcv inhibitor - Google Patents

Solid state forms of a potent hcv inhibitor

Info

Publication number
TN2013000135A1
TN2013000135A1 TNP2013000135A TN2013000135A TN2013000135A1 TN 2013000135 A1 TN2013000135 A1 TN 2013000135A1 TN P2013000135 A TNP2013000135 A TN P2013000135A TN 2013000135 A TN2013000135 A TN 2013000135A TN 2013000135 A1 TN2013000135 A1 TN 2013000135A1
Authority
TN
Tunisia
Prior art keywords
solid state
state forms
hcv inhibitor
potent hcv
potent
Prior art date
Application number
TNP2013000135A
Other languages
French (fr)
Inventor
Rolf-Stefan Brickl
Shirlynn Chen
Jihchin Chung
Mayur Suryakant Dudhedia
Danping Li
Siddharthya Mujumdar
Chitra Telang
Richard Varsolona
Zeren Wang
Zhi-Hui Lu
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/052869 external-priority patent/WO2012044520A1/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TN2013000135A1 publication Critical patent/TN2013000135A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

This invention relates to novel sodium salt forms of the following Compound (1), and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of Hepatitis C Viral (HCV) infection.
TNP2013000135A 2011-09-23 2013-03-27 Solid state forms of a potent hcv inhibitor TN2013000135A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/052869 WO2012044520A1 (en) 2010-09-30 2011-09-23 Solid state forms of a potent hcv inhibitor

Publications (1)

Publication Number Publication Date
TN2013000135A1 true TN2013000135A1 (en) 2014-06-25

Family

ID=54360803

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000135A TN2013000135A1 (en) 2011-09-23 2013-03-27 Solid state forms of a potent hcv inhibitor

Country Status (1)

Country Link
TN (1) TN2013000135A1 (en)

Similar Documents

Publication Publication Date Title
MY153093A (en) Crystalline forms of a 2-thiazolyl-4-quinolinyl-oxy derivative, a potent hcv inhibitor
EA026667B9 (en) Pharmaceutical composition for treating hepatitis c virus
PH12015502056A1 (en) Benzothiazole compounds and their pharmaceutical use
UA113956C2 (en) PIRIMIDIN DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS
MD20140136A2 (en) Inhibitors of hepatitis C virus
PH12013500015A1 (en) 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
PH12014501134A1 (en) 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
PH12013501543A1 (en) Hepatitis c virus inhibitors
TN2012000358A1 (en) Hepatitis c virus inhibitors
EP2555622A4 (en) Hepatitis c virus inhibitors
MY160130A (en) Hepatitis c virus inhibitors
MX2012008221A (en) Inhibitors of flaviviridae viruses.
MX2012000959A (en) Inhibitors of flaviviridae viruses.
MX2012008211A (en) Inhibitors of flaviviridae viruses.
IN2012DN01855A (en)
PH12014501283A1 (en) 4`-azido, 3``-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication
MX2013001237A (en) Hepatitis c virus inhibitors.
WO2013059278A3 (en) Hepatitis c virus inhibitors
WO2011150190A3 (en) Hcv inhibitor compounds and methods of use thereof
MY167881A (en) Process for preparing antiviral compounds
PH12013502177A1 (en) Hepatitis c virus inhibitors
JO3281B1 (en) Benzofuran Compounds for the Treatment of Hepatitis C Virus Infections
MX360161B (en) Process for preparing antiviral compounds.
PH12013500558A1 (en) Solid state forms of a potent hcv inhibitor
MY169288A (en) Process for preparing an antiviral compound